Cue Biopharma, Inc. - Common Stock (NQ:CUE)

20.56 +2.24 (+12.23%)

Delayed Quote Updated: 11:59 AM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cue Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

In today's session, these stocks are experiencing unusual volume. ↗

December 26, 2025

Unusual volume stocks are being observed in Friday's session.

Via Chartmill

Which stocks are moving on Friday? ↗

December 19, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are gapping on Friday? ↗

December 19, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

December 19, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

These stocks are moving in today's after hours session ↗

December 18, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 09, 2025

Via Benzinga

Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected ↗

August 12, 2025

Cue Biopharma beats Q2 2025 revenue and EPS estimates, reports $2.95M revenue (-$0.09 EPS). Stock rises 2% amid FDA progress for CUE-401 autoimmune therapy.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 16, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

July 16, 2025

The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 01, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 01, 2025

As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 15, 2025

Via Benzinga

Discover the top movers in Monday's pre-market session. ↗

April 07, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 07, 2025

Via Benzinga

What's Going On With Cue Biopharma Shares Tuesday? ↗

April 01, 2025

Cue reported 2024 fiscal-year earnings on Monday after the market closed.

Via Benzinga

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

March 31, 2025

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 29, 2024

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

November 25, 2024

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

November 14, 2024

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Announces Strategic Organizational Transition

November 14, 2024

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

November 12, 2024

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

November 08, 2024

From Cue Biopharma, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 07, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.